The Venture Codex Logo

The Venture Codex

Vedeng

Room 301, Floor 3, Building 2, No. 2 Yongshun Road, Qinhuai District, Nanjing, Jiangsu, 210000, China

Overview

Beideng Medical is a digital, self-operated B2B medical-device supply-chain platform that connects upstream manufacturers with downstream distributors and medical institutions. The company focuses on simplifying procurement for grassroots and private medical markets through comprehensive digital, online and self-operated supply-chain services. After the round it will accelerate platform digitalization, online and intelligent upgrades, deepen localized services, further integrate upstream supply, and build logistics, warehousing, after-sales and marketing middle-office capabilities. The platform curates more than 20,000 SKUs, has strategic cooperation with 300+ domestic and international brands, and a channel network covering 970,000 grassroots and private medical customers. Beideng works with 300+ prefecture-level cities, 2,500+ counties, 10,000+ active distributor customers and 20,000+ private medical institutions; its cross-border e-commerce serves 20+ countries and regions. Sales revenue has grown rapidly in recent years, gross margins have improved, and the company has achieved overall profitability. Vedeng Corporation operates a B2B e-commerce portal focused on medical equipment in China. The platform facilitates online transactions of medical devices for business customers. The company completed a Series A fundraising that brought in RMB65 million (US$9.4 million). Investors in the round were Zhongwei Fund, Oriental Fortune Capital and Puhua Capital. Zhongwei Fund is described in the article as an investment platform owned by the former parent company of Meinian Onehealth Healthcare Holdings Co., Ltd. The article does not provide additional operating metrics or detailed plans for the use of proceeds.

Total raised
$24M
Funding rounds
2
Latest round
Series B
Latest activity
May 2020

Industries

  • E-Commerce
  • Health Care
  • Hospital
  • Medical
Visit website

Recent funding

  1. Series B

    May 2020

    $14M

  2. Series A

    Nov 2016

    $9M

Team

  • Haibo Ding

    Chief Executive Officer & Founder